Reports
Sale
India Intravenous Solutions Market Share, Size, Trends, Growth, Forecast: By Type of Intravenous Solutions: Crystalloids, Colloids, Parenteral Nutrition Solutions, Blood-Derived Products, Others; By Application: Fluid Replacement Therapy, Electrolyte Imbalance Correction, Others; By End-User; Market Dynamics; Suppliers Landscape; 2024-2032
India Intravenous Solutions Market Outlook
The India intravenous solutions market size was valued at INR 171.44 billion in 2023, driven by its wide utility in various healthcare domains ranging from surgical to post-surgical care across the region. The market is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, with the values likely to rise from INR 185.67 billion in 2024 to INR 351.37 billion by 2032.
Intravenous Solutions: Introduction
Intravenous solutions are injected into a patient’s vein to prevent or treat electrolyte imbalance or dehydration in the body. It is injected through an IV (intravenous) tube. It may be used to restore electrolytes in people who are suffering from diarrhea or vomiting, have exercised too much, have burns or serious injuries, or have undergone surgery. Intravenous solutions contain various nutrients. The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic.
India Intravenous Solutions Market Analysis
The development of the healthcare infrastructure in the country is a key trend supporting the growth of the India intravenous solutions market value. With more hospitals and medical care centres available across the country, including in smaller towns, the demand for intravenous solutions is expected to rise. In addition, there is a heightened focus on providing apt neonatal care to decrease the infant mortality rate. As intravenous solutions provide instant effect, they have been widely adopted to treat malnutrition in infants, women as well as children in the region.
The rising prevalence of cancer is another factor contributing to the market growth. Treatments like radiation and chemotherapy also rely on intravenous solutions for efficient response.
Specific programs like the Rashtriya Kishor Swasthya Karyakram, Ayushman Bharat which includes PM-JAY, India’s biggest government sponsored health insurance scheme, along with the National Digital Health Mission have been initiated by the government to make the masses informed and empowered to make appropriate health decisions. There is another allocation INR 5,000 crore to boost the medical healthcare research and development in pharmaceutical sector. Moreover, with the integration of latest technologies like artificial intelligence and data analytics in medical ecosystem, we can expect the India intravenous solutions market share to expand globally as well.
India Intravenous Solutions Market Segmentation
Market Breakup by Type of Intravenous Solutions
- Crystalloids
- Colloids
- Parenteral Nutrition Solutions
- Blood-Derived Products
- Others
Market Breakup by Application
- Fluid Replacement Therapy
- Electrolyte Imbalance Correction
- Blood Transfusion
- Parenteral Nutrition
- Chemotherapy
- Rehydration
Market Breakup by End-User
- Hospitals
- Clinics
- Ambulatory Surgical Centres
- Home Healthcare Settings
India Intravenous Solutions Market Overview
India intravenous solutions market demand has observed a significant upswing, owing to their increased application in several healthcare conditions, including surgery, chemotherapy, blood transfusions as well as emergency medicines. This increased usage can be accredited to its relatively higher efficacy and rapid response capabilities to those in need. Moreover, the population dynamics of the region are quite diverse, ranging from pediatrics to geriatrics. Intravenous solutions, being easily accessible and affordable, are heavily used to cater to different dynamics.
India intravenous solutions market growth is driven by a diverse range of government as well as private sector initiatives to improve the healthcare system, build high-capacity hospitals and clinics for increasing population and facilitate better public health opportunities. In addition, there is high emphasis on inviting Foreign Direct Investment (FDI) with a vision to foster growth in the healthcare sector.
India Intravenous Solutions Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Piramal Enterprises Limited
- Hospira (Pfizer Inc.)
- Amsino International Inc.
- ICU Medical, Inc.
- Sami Labs Limited
- Troikaa Pharmaceuticals Ltd.
- Neiss Labs Pvt. Ltd.
- Ketan Pharma
- Abaris Healthcare Pvt. Ltd.
- Parenteral Drugs (India) Ltd.
- Arbro Pharmaceuticals Limited
- Neon Laboratories Ltd.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type of Intravenous Solutions |
|
| Breakup by Application |
|
| Breakup by End-User |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 India Intravenous Solutions Market Overview
3.1 India Intravenous Solutions Market Historical Value (2017-2023)
3.2 India Intravenous Solutions Market Forecast Value (2024-2032)
4 India Intravenous Solutions Market Landscape
4.1 India Intravenous Solutions Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 India Intravenous Solutions Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
5 India Intravenous Solutions Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 India Intravenous Solutions Market Segmentation
6.1 India Intravenous Solutions Market by Type of Intravenous Solutions
6.1.1 Market Overview
6.1.2 Crystalloids
6.1.3 Colloids
6.1.4 Parenteral Nutrition Solutions
6.1.5 Blood-Derived Products
6.1.6 Others
6.2 India Intravenous Solutions Market by Application
6.2.1 Market Overview
6.2.2 Fluid Replacement Therapy
6.2.3 Electrolyte Imbalance Correction
6.2.4 Blood Transfusion
6.2.5 Parenteral Nutrition
6.2.6 Chemotherapy
6.2.7 Rehydration
6.3 India Intravenous Solutions Market by End-User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centres
6.3.5 Home Healthcare Settings
7 Patent Analysis
7.1 Analysis by Type of Patent
7.2 Analysis by Publication year
7.3 Analysis by Issuing Authority
7.4 Analysis by Patent Age
7.5 Analysis by CPC Analysis
7.6 Analysis by Patent Valuation
7.7 Analysis by Key Players
8 Grants Analysis
8.1 Analysis by year
8.2 Analysis by Amount Awarded
8.3 Analysis by Issuing Authority
8.4 Analysis by Grant Application
8.5 Analysis by Funding Institute
8.6 Analysis by NIH Departments
8.7 Analysis by Recipient Organization
9 Regulatory Framework
10 Suppliers Landscape
10.1 Baxter International Inc.
10.1.1 Financial Analysis
10.1.2 Product Portfolio
10.1.3 Demographic Reach and Achievements
10.1.4 Mergers and Acquisitions
10.1.5 Certifications
10.2 B. Braun Melsungen AG
10.2.1 Financial Analysis
10.2.2 Product Portfolio
10.2.3 Demographic Reach and Achievements
10.2.4 Mergers and Acquisitions
10.2.5 Certifications
10.3 Fresenius SE & Co. KGaA
10.3.1 Financial Analysis
10.3.2 Product Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Mergers and Acquisitions
10.3.5 Certifications
10.4 Piramal Enterprises Limited
10.4.1 Financial Analysis
10.4.2 Product Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Mergers and Acquisitions
10.4.5 Certifications
10.5 Hospira (Pfizer Inc.)
10.5.1 Financial Analysis
10.5.2 Product Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Mergers and Acquisitions
10.5.5 Certifications
10.6 Amsino International Inc.
10.6.1 Financial Analysis
10.6.2 Product Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Mergers and Acquisitions
10.6.5 Certifications
10.7 ICU Medical, Inc.
10.7.1 Financial Analysis
10.7.2 Product Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Mergers and Acquisitions
10.7.5 Certifications
10.8 Sami Labs Limited
10.8.1 Financial Analysis
10.8.2 Product Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Mergers and Acquisitions
10.8.5 Certifications
10.9 Troikaa Pharmaceuticals Ltd.
10.9.1 Financial Analysis
10.9.2 Product Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Mergers and Acquisitions
10.9.5 Certifications
10.10 Neiss Labs Pvt. Ltd.
10.10.1 Financial Analysis
10.10.2 Product Portfolio
10.10.3 Demographic Reach and Achievements
10.10.4 Mergers and Acquisitions
10.10.5 Certifications
10.11 Ketan Pharma
10.11.1 Financial Analysis
10.11.2 Product Portfolio
10.11.3 Demographic Reach and Achievements
10.11.4 Mergers and Acquisitions
10.11.5 Certifications
10.12 Abaris Healthcare Pvt. Ltd.
10.12.1 Financial Analysis
10.12.2 Product Portfolio
10.12.3 Demographic Reach and Achievements
10.12.4 Mergers and Acquisitions
10.12.5 Certifications
10.13 Parenteral Drugs (India) Ltd.
10.13.1 Financial Analysis
10.13.2 Product Portfolio
10.13.3 Demographic Reach and Achievements
10.13.4 Mergers and Acquisitions
10.13.5 Certifications
10.14 Arbro Pharmaceuticals Limited
10.14.1 Financial Analysis
10.14.2 Product Portfolio
10.14.3 Demographic Reach and Achievements
10.14.4 Mergers and Acquisitions
10.14.5 Certifications
10.15 Neon Laboratories Ltd.
10.15.1 Financial Analysis
10.15.2 Product Portfolio
10.15.3 Demographic Reach and Achievements
10.15.4 Mergers and Acquisitions
10.15.5 Certifications
11 India Intravenous Solutions Market - Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
12 Key Opinion Leaders (KOL) Insights (Additional Insight)
13 Company Competitiveness Analysis (Additional Insight)
13.1 Very Small Companies
13.2 Small Companies
13.3 Mid-Sized Companies
13.4 Large Companies
13.5 Very Large Companies
14 Payment Methods (Additional Insight)
14.1 Government Funded
14.2 Private Insurance
14.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about INR 171.44 billion in 2023, driven by the increased application of intravenous solutions across several healthcare domains.
The market is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032, with the values likely to rise to INR 351.37 billion by 2032.
The high market demand is majorly driven by the ability of intravenous solutions to provide rapid response rate to patients, along with their higher efficacy and wider applications.
The current market trend revolves around increased government intervention and initiatives to offer quality healthcare services to the masses. Health initiatives like the Rashtriya Kishor Swasthya Karyakram, Ayushman Bharat and the National Digital Health Mission are some common examples set up by the Indian government.
Based on the type of intravenous solutions, the market is divided into crystalloids, colloids, parenteral nutrition solutions, and blood-derived products, among others.
Common application include fluid replacement therapy, electrolyte imbalance correction, blood transfusion, parenteral nutrition, chemotherapy, and rehydration.
Major end users in the market include hospitals, clinics, ambulatory surgical centres, and home healthcare settings.
Key players involved in the market are Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Piramal Enterprises Limited, Hospira (Pfizer Inc.), Amsino International Inc., ICU Medical, Inc., Sami Labs Limited, Troikaa Pharmaceuticals Ltd., Neiss Labs Pvt. Ltd., Ketan Pharma, Abaris Healthcare Pvt. Ltd., Parenteral Drugs (India) Ltd., Arbro Pharmaceuticals Limited and Neon Laboratories Ltd.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER